Table 1.
Patient characteristics
| Non-diabetics (%) | Diabetic (%) | p value | |
|---|---|---|---|
| N | 1346 | 764 | |
| Male | 1215 (82) | 726 (85) | 0.033 |
| Age (mean ± SD) | 62.2 ± 14 | 66.3 ± 9.4 | <0.001 |
| Age ≥75 | 256 (19) | 163 (21) | 0.154 |
| Prior VA | 452 (34) | 273 (31) | 0.252 |
| Primary prevention | 901 (66) | 589 (76) | <0.001 |
| Ischemic heart disease | 904 (67) | 625 (82) | <0.001 |
| History of AF | 254 (19) | 170 (22) | <0.001 |
| Chronic lung disease | 85 (6) | 118 (16) | <0.001 |
| Smoker | 379 (29) | 272 (36) | 0.003 |
| Dialysis | 12 (1) | 23 (4) | <0.001 |
| Sleep apnea | 81 (6) | 89 (12) | <0.001 |
| Prior CVA | 98 (7) | 67 (9) | <0.001 |
| Atrial fibrillation | 30 (2) | 35 (1) | 0.05 |
| NYHA ≥3 | 377 (28) | 326 (43) | <0.001 |
| EF | 30.5 ± 11.6 | 28.0 ± 8.3 | <0.001 |
| QRS duration | 115.8 ± 29.8 | 124.6 ± 30.9 | <0.01 |
| CRTD | 412 (31) | 332 (43) | <0.001 |
| ACE inhibitor | 921 (69) | 603 (79) | <0.001 |
| Beta Blocker | 1044 (78) | 666 (87) | <0.001 |
VA ventricular arrhythmia, CVA cerebrovascular accident, AF atrial fibrillation, NYHA New York Heart Association, EF ejection fraction, CRTD cardiac resynchronization therapy-defibrillator, ACE angiotensin converter enzyme